IDEAYA Biosciences stock jumps as February Citi, Evercore fireside chats near
IDEAYA Biosciences shares rose 5.1% to $33.83 Monday, outpacing biotech indexes. The company confirmed two investor events in February, including talks from senior executives. Traders are focused on upcoming trial results for IDEAYA’s uveal melanoma program and any updates on FDA filing plans.
